Although the role of HLA DRB1*11 in liver diseases has been poorly investigated, in the available literature, this allele has been significantly associated with resistance to chronic HBV and HCV infection in Chinese, Brazilian, and European populations [45,46], and with a weak protection to AIH in studies conducted on Iranian and Iraqi groups of patients [47,48]. This evidence concerns the gene HLA-DRB1 and liver disorder.